Is Eptifibatide a Viable and Safe Option as Stand-Alone Therapy for Acute Ischemic Stroke Patients? (P2.278)

Conclusion: In patients who are not candidates for IV tPA eptifibatide may be a safe and efficacious alternative. None of the patients who were started on eptifibatide had bleeding complications and they had a statistically significant improvement in their level of disability and stroke severity at discharge. To better evaluate the efficacy of eptifibatide, a larger, prospective study should be initiatedDisclosure: Dr. Korya has nothing to disclose. Dr. Moussavi has nothing to disclose. Dr. Mehta has nothing to disclose. Dr. Brar has nothing to disclose. Dr. Chahal has nothing to disclose. Dr. Daniel has nothing to disclose. Dr. Samaan has nothing to disclose. Dr. Panezai has nothing to disclose. Dr. Kirmani has nothing to disclose.

Source: Neurology - April 3, 2016 Category: Neurology Authors: Mehta, S., Moussavi, M., Korya, D., Brar, J., Chahal, H., Daniel, J., Samaan, M., Panezai, S., Kirmani, J. Tags: Acute Therapy: Thrombolysis and Adjuvant Therapy Source Type: research